More Amici Urge Supreme Court To Take Up Entresto Patent Case

( October 9, 2025, 1:14 PM EDT) -- WASHINGTON, D.C. — The Public Interest Patent Law Institute (PIPLI) tells the U.S. Supreme Court in an Oct. 8 amicus curiae brief that it should grant a generic drugmaker’s petition for a writ of certiorari in a dispute over the patent for heart medication Entresto, arguing that the Federal Circuit U.S. Court of Appeals has created conflicting strategies on how to treat after-arising technology....

Attached Documents

Related Sections